![Tacey Viegas](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tacey Viegas
Corporate Officer/Principal presso BIOCRYST PHARMACEUTICALS, INC.
Patrimonio netto: 561 484 $ in data 30/06/2024
Profilo
Tacey Viegas is currently the Executive Director of Product Development at BioCryst Pharmaceuticals, Inc. He also holds positions as the Chief Operating Officer at Serina Therapeutics (AL), Inc. and as the Secretary and Chief Operating Officer at Serina Therapeutics, Inc. Previously, he served as the Director of Product Development at MDV Technologies, Inc. from 1989 to 1994.
Dr. Viegas holds a graduate and doctorate degree from the University of Mississippi and an undergraduate degree from the University of Bangalore.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
0.70% | 10/06/2024 | 58 610 ( 0.70% ) | 561 484 $ | 30/06/2024 |
Posizioni attive di Tacey Viegas
Società | Posizione | Inizio |
---|---|---|
BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Serina Therapeutics, Inc.
![]() Serina Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Serina Therapeutics, Inc. is a pharmaceutical company, which engages in the development of polymer technology. Its POZ technology is designed to optimize drug delivery to maximize compliance, therapeutic outcomes, safety, and quality of life for patients. It also offers drugs to treat neurological diseases, cancer, and pain. The company was founded by J. Milton Harris and Michael D. Bentley in 2006 and is headquartered in Huntsville, AL. | Direttore operativo | 01/11/2006 |
Precedenti posizioni note di Tacey Viegas
Società | Posizione | Fine |
---|---|---|
MDV Technologies, Inc.
![]() MDV Technologies, Inc. Medical SpecialtiesHealth Technology Part of Alliance Pharmaceutical Corp., MDV Technologies, Inc. develops and makes medical products. The company is based in Dearborn, MI. MDV Technologies was acquired by Alliance Pharmaceutical Corp. on November 14, 1996 for $35.50 million. | Corporate Officer/Principal | 02/01/1994 |
Formazione di Tacey Viegas
University of Bangalore | Undergraduate Degree |
University of Mississippi | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 2 |
---|---|
Serina Therapeutics, Inc.
![]() Serina Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Serina Therapeutics, Inc. is a pharmaceutical company, which engages in the development of polymer technology. Its POZ technology is designed to optimize drug delivery to maximize compliance, therapeutic outcomes, safety, and quality of life for patients. It also offers drugs to treat neurological diseases, cancer, and pain. The company was founded by J. Milton Harris and Michael D. Bentley in 2006 and is headquartered in Huntsville, AL. | Commercial Services |
MDV Technologies, Inc.
![]() MDV Technologies, Inc. Medical SpecialtiesHealth Technology Part of Alliance Pharmaceutical Corp., MDV Technologies, Inc. develops and makes medical products. The company is based in Dearborn, MI. MDV Technologies was acquired by Alliance Pharmaceutical Corp. on November 14, 1996 for $35.50 million. | Health Technology |
- Borsa valori
- Insiders
- Tacey Viegas